DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $203,577 | -4.9% | 767 | -10.0% | 0.13% | -5.6% |
| Q3 2022 | $214,000 | -2.3% | 852 | -1.2% | 0.14% | -0.7% |
| Q2 2022 | $219,000 | -13.4% | 862 | 0.0% | 0.14% | +1.4% |
| Q1 2022 | $253,000 | -10.9% | 862 | 0.0% | 0.14% | -7.2% |
| Q4 2021 | $284,000 | +8.0% | 862 | -0.3% | 0.15% | -2.6% |
| Q3 2021 | $263,000 | -4.0% | 865 | -15.2% | 0.16% | -3.1% |
| Q2 2021 | $274,000 | -44.5% | 1,020 | -53.5% | 0.16% | -40.1% |
| Q1 2021 | $494,000 | -5.4% | 2,195 | -6.6% | 0.27% | -13.5% |
| Q4 2020 | $522,000 | -35.7% | 2,350 | -37.7% | 0.31% | -43.1% |
| Q3 2020 | $812,000 | +54.7% | 3,772 | +45.2% | 0.55% | +34.1% |
| Q2 2020 | $525,000 | +2.3% | 2,597 | -29.9% | 0.41% | -14.5% |
| Q1 2020 | $513,000 | +32.2% | 3,705 | +46.4% | 0.48% | +53.4% |
| Q4 2019 | $388,000 | +6.3% | 2,530 | 0.0% | 0.31% | -2.2% |
| Q3 2019 | $365,000 | +0.8% | 2,530 | 0.0% | 0.32% | +0.6% |
| Q2 2019 | $362,000 | +4.3% | 2,530 | -3.8% | 0.32% | +2.6% |
| Q1 2019 | $347,000 | +29.0% | 2,630 | +1.0% | 0.31% | +15.8% |
| Q4 2018 | $269,000 | -4.9% | 2,605 | 0.0% | 0.27% | +12.7% |
| Q3 2018 | $283,000 | -11.3% | 2,605 | -19.3% | 0.24% | -16.9% |
| Q2 2018 | $319,000 | +0.9% | 3,230 | 0.0% | 0.28% | +1.8% |
| Q1 2018 | $316,000 | +5.3% | 3,230 | 0.0% | 0.28% | +3.3% |
| Q4 2017 | $300,000 | +8.3% | 3,230 | 0.0% | 0.27% | +5.9% |
| Q3 2017 | $277,000 | +1.5% | 3,230 | 0.0% | 0.26% | +1.2% |
| Q2 2017 | $273,000 | -1.1% | 3,230 | 0.0% | 0.25% | -2.3% |
| Q1 2017 | $276,000 | +10.0% | 3,230 | 0.0% | 0.26% | +10.7% |
| Q4 2016 | $251,000 | -0.8% | 3,230 | 0.0% | 0.23% | +2.2% |
| Q3 2016 | $253,000 | -22.4% | 3,230 | 0.0% | 0.23% | -21.6% |
| Q2 2016 | $326,000 | +6.5% | 3,230 | 0.0% | 0.29% | +3.9% |
| Q1 2016 | $306,000 | +2.0% | 3,230 | 0.0% | 0.28% | -11.1% |
| Q4 2015 | $300,000 | – | 3,230 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |